Global Sorafenib Tablet Market Research Report 2025(Status and Outlook)

Report Overview

Sorafenib tablets are an oral multi-kinase inhibitor primarily used in the treatment of advanced renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and differentiated thyroid carcinoma (DTC). The drug works by targeting Raf kinases and receptor tyrosine kinases involved in tumor growth and angiogenesis, making it a critical option for patients with limited therapeutic alternatives. The global market for sorafenib is driven by increasing cancer prevalence, particularly in liver and kidney cancers, alongside growing demand for targeted therapies. However, market expansion faces challenges such as patent expirations, leading to the entry of generics, which has intensified price competition. Regions like North America and Europe dominate sales due to high healthcare expenditure and early adoption of advanced therapies, while emerging markets in Asia-Pacific show significant growth potential due to rising cancer incidence and improving healthcare infrastructure. Key players include Bayer AG (the originator) and several generic manufacturers, with ongoing research exploring combination therapies to enhance efficacy. Regulatory approvals, reimbursement policies, and strategic collaborations further shape market dynamics, making sorafenib a competitive yet evolving segment in the oncology drug market.

The global Sorafenib Tablet market size was estimated at USD 154.5 million in 2024, exhibiting a CAGR of 4.50% during the forecast period.

This report provides a deep insight into the global Sorafenib Tablet market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Sorafenib Tablet Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Sorafenib Tablet market in any manner.

Global Sorafenib Tablet Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Bayer

Natco Pharma

Cipla

Mylan

Aprazer

MBA Pharmaceuticals Pvt Ltd

Teva

Aetos Pharma

healthiza

Market Segmentation (by Type)

Patented Drugs

Generic Drugs

Market Segmentation (by Application)

Kidney Cancer

Liver Cancer

Thyroid Cancer

Other

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Sorafenib Tablet Market

Overview of the regional outlook of the Sorafenib Tablet Market:

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Sorafenib Tablet Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Sorafenib Tablet, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Sorafenib Tablet
1.2 Key Market Segments
1.2.1 Sorafenib Tablet Segment by Type
1.2.2 Sorafenib Tablet Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Sorafenib Tablet Market Overview
2.1 Global Market Overview
2.1.1 Global Sorafenib Tablet Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Sorafenib Tablet Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Sorafenib Tablet Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Sorafenib Tablet Product Life Cycle
3.3 Global Sorafenib Tablet Sales by Manufacturers (2020-2025)
3.4 Global Sorafenib Tablet Revenue Market Share by Manufacturers (2020-2025)
3.5 Sorafenib Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Sorafenib Tablet Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Sorafenib Tablet Market Competitive Situation and Trends
3.8.1 Sorafenib Tablet Market Concentration Rate
3.8.2 Global 5 and 10 Largest Sorafenib Tablet Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Sorafenib Tablet Industry Chain Analysis
4.1 Sorafenib Tablet Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Sorafenib Tablet Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Sorafenib Tablet Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Sorafenib Tablet Market
5.7 ESG Ratings of Leading Companies
6 Sorafenib Tablet Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Sorafenib Tablet Sales Market Share by Type (2020-2025)
6.3 Global Sorafenib Tablet Market Size Market Share by Type (2020-2025)
6.4 Global Sorafenib Tablet Price by Type (2020-2025)
7 Sorafenib Tablet Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Sorafenib Tablet Market Sales by Application (2020-2025)
7.3 Global Sorafenib Tablet Market Size (M USD) by Application (2020-2025)
7.4 Global Sorafenib Tablet Sales Growth Rate by Application (2020-2025)
8 Sorafenib Tablet Market Sales by Region
8.1 Global Sorafenib Tablet Sales by Region
8.1.1 Global Sorafenib Tablet Sales by Region
8.1.2 Global Sorafenib Tablet Sales Market Share by Region
8.2 Global Sorafenib Tablet Market Size by Region
8.2.1 Global Sorafenib Tablet Market Size by Region
8.2.2 Global Sorafenib Tablet Market Size Market Share by Region
8.3 North America
8.3.1 North America Sorafenib Tablet Sales by Country
8.3.2 North America Sorafenib Tablet Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Sorafenib Tablet Sales by Country
8.4.2 Europe Sorafenib Tablet Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Sorafenib Tablet Sales by Region
8.5.2 Asia Pacific Sorafenib Tablet Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Sorafenib Tablet Sales by Country
8.6.2 South America Sorafenib Tablet Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Sorafenib Tablet Sales by Region
8.7.2 Middle East and Africa Sorafenib Tablet Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Sorafenib Tablet Market Production by Region
9.1 Global Production of Sorafenib Tablet by Region(2020-2025)
9.2 Global Sorafenib Tablet Revenue Market Share by Region (2020-2025)
9.3 Global Sorafenib Tablet Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Sorafenib Tablet Production
9.4.1 North America Sorafenib Tablet Production Growth Rate (2020-2025)
9.4.2 North America Sorafenib Tablet Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Sorafenib Tablet Production
9.5.1 Europe Sorafenib Tablet Production Growth Rate (2020-2025)
9.5.2 Europe Sorafenib Tablet Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Sorafenib Tablet Production (2020-2025)
9.6.1 Japan Sorafenib Tablet Production Growth Rate (2020-2025)
9.6.2 Japan Sorafenib Tablet Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Sorafenib Tablet Production (2020-2025)
9.7.1 China Sorafenib Tablet Production Growth Rate (2020-2025)
9.7.2 China Sorafenib Tablet Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Bayer
10.1.1 Bayer Basic Information
10.1.2 Bayer Sorafenib Tablet Product Overview
10.1.3 Bayer Sorafenib Tablet Product Market Performance
10.1.4 Bayer Business Overview
10.1.5 Bayer SWOT Analysis
10.1.6 Bayer Recent Developments
10.2 Natco Pharma
10.2.1 Natco Pharma Basic Information
10.2.2 Natco Pharma Sorafenib Tablet Product Overview
10.2.3 Natco Pharma Sorafenib Tablet Product Market Performance
10.2.4 Natco Pharma Business Overview
10.2.5 Natco Pharma SWOT Analysis
10.2.6 Natco Pharma Recent Developments
10.3 Cipla
10.3.1 Cipla Basic Information
10.3.2 Cipla Sorafenib Tablet Product Overview
10.3.3 Cipla Sorafenib Tablet Product Market Performance
10.3.4 Cipla Business Overview
10.3.5 Cipla SWOT Analysis
10.3.6 Cipla Recent Developments
10.4 Mylan
10.4.1 Mylan Basic Information
10.4.2 Mylan Sorafenib Tablet Product Overview
10.4.3 Mylan Sorafenib Tablet Product Market Performance
10.4.4 Mylan Business Overview
10.4.5 Mylan Recent Developments
10.5 Aprazer
10.5.1 Aprazer Basic Information
10.5.2 Aprazer Sorafenib Tablet Product Overview
10.5.3 Aprazer Sorafenib Tablet Product Market Performance
10.5.4 Aprazer Business Overview
10.5.5 Aprazer Recent Developments
10.6 MBA Pharmaceuticals Pvt Ltd
10.6.1 MBA Pharmaceuticals Pvt Ltd Basic Information
10.6.2 MBA Pharmaceuticals Pvt Ltd Sorafenib Tablet Product Overview
10.6.3 MBA Pharmaceuticals Pvt Ltd Sorafenib Tablet Product Market Performance
10.6.4 MBA Pharmaceuticals Pvt Ltd Business Overview
10.6.5 MBA Pharmaceuticals Pvt Ltd Recent Developments
10.7 Teva
10.7.1 Teva Basic Information
10.7.2 Teva Sorafenib Tablet Product Overview
10.7.3 Teva Sorafenib Tablet Product Market Performance
10.7.4 Teva Business Overview
10.7.5 Teva Recent Developments
10.8 Aetos Pharma
10.8.1 Aetos Pharma Basic Information
10.8.2 Aetos Pharma Sorafenib Tablet Product Overview
10.8.3 Aetos Pharma Sorafenib Tablet Product Market Performance
10.8.4 Aetos Pharma Business Overview
10.8.5 Aetos Pharma Recent Developments
10.9 healthiza
10.9.1 healthiza Basic Information
10.9.2 healthiza Sorafenib Tablet Product Overview
10.9.3 healthiza Sorafenib Tablet Product Market Performance
10.9.4 healthiza Business Overview
10.9.5 healthiza Recent Developments
11 Sorafenib Tablet Market Forecast by Region
11.1 Global Sorafenib Tablet Market Size Forecast
11.2 Global Sorafenib Tablet Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Sorafenib Tablet Market Size Forecast by Country
11.2.3 Asia Pacific Sorafenib Tablet Market Size Forecast by Region
11.2.4 South America Sorafenib Tablet Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Sorafenib Tablet by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Sorafenib Tablet Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Sorafenib Tablet by Type (2026-2033)
12.1.2 Global Sorafenib Tablet Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Sorafenib Tablet by Type (2026-2033)
12.2 Global Sorafenib Tablet Market Forecast by Application (2026-2033)
12.2.1 Global Sorafenib Tablet Sales (K Units) Forecast by Application
12.2.2 Global Sorafenib Tablet Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings